Home / Resources / Videos / Szilard Voros, MD: New Panel of Tests (DPMP) Identifies Diabetes and CV Risk Earlier

Szilard Voros, MD: New Panel of Tests (DPMP) Identifies Diabetes and CV Risk Earlier




Szilard Voros, MD, FACC, FSCCT, FAHA, talks about how new panels of test he and his team at Health Diagnostic Laboratory have created can catch diseases earlier. The new Diabetes Prevention & Management Panel (DPMP) grew out of the recognition that up to 70% of the CV patients that the team had been studying had underlying insulin resistance. They began to focus on root causes and put together a panel of biomarker tests for three important components of diabetes; glycemic control, beta cell dysfunction and insulin resistance.

Other videos with Dr. Voros:

Szilard_Voros

Szilard Voros, MD, FACC, FSCCT, FAHA, is a Hungarian-born American cardiologist and globally renowned leading research scientist in advanced cardiovascular imaging, biomarkers, lipoprotein metabolism and genomics. He currently serves as an Associate Professor of Medicine/Cardiology and Radiology, and Director of Advanced Cardiovascular MR and CT Research at the Department of Radiology and Cardiology at Stony Brook University Medical Center, State University of New York. He previously served as the Chief Scientific Officer, Chief of Cardiovascular Prevention, and Medical Director of Cardiac MR and CT at Piedmont Hospital in Atlanta, Georgia, and as a Clinical Associate Professor of Medicine at the Medical College of Georgia. He is a founding member and Fellow of the Society of Cardiovascular Computed Tomography (FSCCT), Fellow of the American College of Cardiology (FACC) and Fellow of the American Heart Association (FAHA).